Perinatal Outcomes in HIV Positive Pregnant Women with Concomitant Sexually Transmitted Infections

Table 1

Key demographic and clinical characteristics of study population.

Characteristics	All pregnancies; ()
Age (years) ()^*	27.5 ± 6.2
Maternal wt. (lbs) ()^*	162.3 ± 46.4
Race ()
Black	355 (85.7%)
Hispanic	29 (7.0%)
White	20 (4.8%)
Asian	6 (1.4%)
Gravidity ()
G1	78 (18.8%)
G2 or 3	189 (45.7%)
G4+	148 (35.7%)
Prior preterm birth ()	57 (13.8%)
Perinatally infected HIV positive mom	20 (5.0%)
Time since HIV infection diagnosis ()
<1 year	65 (16.3%)
1–5 years	174 (43.5%)
>5–10	93 (23.3%)
>10 years	68 (17.0%)
CD4 count at entry ()^†	352.0 (198.0, 564.0)
Using antiretroviral medications ()	401 (96.9%)
Duration of antiretroviral use ()
Not using medications	13 (3.1%)
<1 month	18 (4.3%)
1–5 months	282 (68.1%)
6–12 months	74 (17.9%)
>12 months	27 (6.5%)

Data are number (%) unless otherwise specified.
^*Mean ± SD, ^†IQR-Interquartile range.